Rand, S., Caiels, J. (2015). Using proxies to assess quality of life: A review of the issues and challenges. Discussion paper. Quality and outcomes of person-centred care policy research unit (QORU). University of Kent. Retrieved December 1, 2020, from https://kar.kent.ac.uk/55009/1/Proxy%20literature%20review%20report%20FINAL.pdf
Jones, J. M., McPherson, C. J., Zimmermann, C., Rodin, G., Le, L. W., & Cohen, S. R. (2011). Assessing agreement between terminally ill cancer patients’ reports of their quality of life and family caregiver and palliative care physician proxy ratings. Journal of Pain and Symptom Management, 42(3), 354–365.
Cohen, M. L., & Hula, W. D. (2020). Patient-reported outcomes and evidence-based practice in speech-language pathology. American Journal of Speech-Language Pathology, 29(1), 357–370.
Food and Drug Administration. (2009). Guidance for industry: Patient-reported outcome measures: Use in medical product development to support labeling claims. Silver Spring, MD: Food and Drug Administration. Retrieved December 1, 2020, from https://www.fda.gov/media/77832/download
European Medicines Agency. (2016). Appendix 2 to the guideline on the evaluation of anticancer medicinal products in man: The use of patient-reported outcome (PRO) measures in oncology studies. London, UK: European Medicines Agency. Retrieve December 1, 2020, from https://www.ema.europa.eu/en/documents/other/appendix-2-guideline-evaluation-anticancer-medicinal-products-man_en.pdf
Powers, J. H., 3rd., Patrick, D. L., Walton, M. K., Marquis, P., Cano, S., Hobart, J., Isaac, M., Vamvakas, S., Slagle, A., Molsen, E., & Burke, L. B. (2017). Clinician-reported outcome assessments of treatment benefit: Report of the ISPOR clinical outcome assessment emerging good practices task force. Value in Health, 20(1), 2–14.
Food and Drug Administration. (2018). Attachment to discussion document for patient-focused drug development public workshop on guidance 3: Select, develop or modify fit-for-purpose clinical outcome assessments—Appendices 2018. Silver Spring, MD: Food and Drug Administration. Retrieved August 4, 2020, from https://www.fda.gov/media/116281/download
Hanson, L. C., Bennett, A. V., Jonsson, M., Kelley, A., Ritchie, C., Saliba, D., Teno, J., & Zimmerman, S. (2020). Selecting outcomes to ensure pragmatic trials are relevant to people living with dementia. Jounal of American Geriatrics Society, 68(Suppl 2), S55–S61.
Pickard, A. S., & Knight, S. J. (2005). Proxy evaluation of health-related quality of life: A conceptual framework for understanding multiple proxy perspectives. Medical Care, 43(5), 493–499.
Matza, L. S., Patrick, D. L., Riley, A. W., Alexander, J. J., Rajmil, L., Pleil, A. M., & Bullinger, M. (2013). Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force. Value in Health, 16(4), 461–479.
De Los Reyes, A., Thomas, S. A., Goodman, K. L., & Kundey, S. M. (2013). Principles underlying the use of multiple informants’ reports. Annual Review of Clinical Psychology, 9, 123–149.
Grill, J. D., Zhou, Y., Karlawish, J., & Elashoff, D. (2015). Frequency and impact of informant replacement in Alzheimer disease research. Alzheimer Disease and Associated Disorders, 29(3), 242–248.
Gruber-Baldini, A. L., Shardell, M., Lloyd, K. D., & Magaziner, J. (2012). Use of proxies and informants. In A. B. Newman & J. A. Cauley (Eds.), The epidemiology of aging (pp. 81–90). Springer.
Mercieca-Bebber, R., Williams, D., Tait, M. A., Rutherford, C., Busija, L., Roberts, N., Wilson, M., Sundaram, C. S., & Roydhouse, J. (2019). Trials with proxy-reported outcomes registered on the Australian New Zealand clinical trials registry (ANZCTR). Quality of Life Research, 28(4), 955–962.
Evans, C. J., Benalia, H., Preston, N. J., Grande, G., Gysels, M., Short, V., Daveson, B. A., Bausewein, C., Todd, C., & Higginson, I. J. (2013). The selection and use of outcome measures in palliative and end-of-life care research: the MORECare international consensus workshop. Journal of Pain and Symptom Management, 46(6), 925–937.
Graham, C. (2016). Incidence and impact of proxy response in measuring patient experience: Secondary analysis of a large postal survey using propensity score matching. International Journal for Quality in Health Care, 28(2), 246–252.
Bjertnaes, O. (2014). Patient-reported experiences with hospitals: Comparison of proxy and patient scores using propensity-score matching. International Journal for Quality in Health Care, 26(1), 34–40.
Todorov, A., & Kirchner, C. (2000). Bias in proxies’ reports of disability: Data from the National Health Interview Survey on disability. American Journal of Public Health, 90(8), 1248–1253.
Chawla, N., Urato, M., Ambs, A., Schussler, N., Hays, R. D., Clauser, S. B., Zaslavsky, A. M., Walsh, K., Schwartz, M., Halpern, M., Gaillot, S., Goldstein, E. H., & Arora, N. H. (2015). Unveiling SEER-CAHPS(R): a new data resource for quality of care research. Jounal of General Internal Medicine, 30(5), 641–650.
Sneeuw, K. C., Aaronson, N. K., Sprangers, M. A., Detmar, S. B., Wever, L. D., & Schornagel, J. H. (1998). Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients. Journal of Clinical Epidemiology, 51(7), 617–631.
Sneeuw, K. C., Aaronson, N. K., de Haan, R. J., & Limburg, M. (1997). Assessing quality of life after stroke. The value and limitations of proxy ratings. Stroke, 28(8), 1541–1549.
Sneeuw, K. C., Aaronson, N. K., Osoba, D., Muller, M. J., Hsu, M. A., Yung, W. K. A., Brada, M., & Newlands, E. S. (1997). The use of significant others as proxy raters of the quality of life of patients with brain cancer. Medical Care, 35(5), 490–506.
Pickard, A. S., Johnson, J. A., Feeny, D. H., Shuaib, A., Carriere, K. C., & Nasser, A. M. (2004). Agreement between patient and proxy assessments of health-related quality of life after stroke using the EQ-5D and health utilities index. Stroke, 35(2), 607–612.
Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015). Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews, 4, 1.
Lobchuk, M. M., & Degner, L. F. (2002). Patients with cancer and next-of-kin response comparability on physical and psychological symptom well-being: Trends and measurement issues. Cancer Nursing, 25(5), 358–374.
McPherson, C. J., & Addington-Hall, J. M. (2003). Judging the quality of care at the end of life: Can proxies provide reliable information? Social Science and Medicine, 56(1), 95–109.
Sneeuw, K. C., Sprangers, M. A., & Aaronson, N. K. (2002). The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease. Journal of Clinical Epidemiology, 55(11), 1130–1143.
Sprangers, M. A., & Aaronson, N. K. (1992). The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: A review. Journal of Clinical Epidemiology, 45(7), 743–760.
Tang, S. T., & McCorkle, R. (2002). Use of family proxies in quality of life research for cancer patients at the end of life: A literature review. Cancer Investigation, 20(7–8), 1086–1104.
von Essen, L. (2004). Proxy ratings of patient quality of life–factors related to patient-proxy agreement. Acta Oncologica, 43(3), 229–234.
Roydhouse, J. K., & Wilson, I. B. (2017). Systematic review of caregiver responses for patient health-related quality of life in adult cancer care. Quality of Life Research, 26(8), 1925–1954.
Liebzeit, D., King, B., & Bratzke, L. (2018). Measurement of function in older adults transitioning from hospital to home: An integrative review. Geriatric Nursing, 39(3), 336–343.
Mayo, N. E., Figueiredo, S., Ahmed, S., & Bartlett, S. J. (2017). Montreal accord on patient-reported outcomes (PROs) use series—Paper 2: Terminology proposed to measure what matters in health. Journal of Clinical Epidemiology, 89, 119–124.
McKown, S., Acquadro, C., Anfray, C., Arnold, B., Eremenco, S., Giroudet, C., Martin, M., & Weiss, D. (2020). Good practices for the translation, cultural adaptation, and linguistic validation of clinician-reported outcome, observer-reported outcome, and performance outcome measures. Journal of Patient Reported Outcomes, 4(1), 89.
Mayo, N. E. (Ed.). (2015). Dictionary of quality of life and health outcomes measurement. ISOQOL.
Cappelleri, J. C., Zou, K. H., Bushmakin, A. G., Alvir, J. M. J., Alemayehu, D., & Symonds, T. (2014). Patient-reported outcomes: measurement, implementation and interpretation. CRC Press.
Caiels, J., Rand, S., Crowther, T., Collins, G., & Forder, J. (2019). Exploring the views of being a proxy from the perspective of unpaid carers and paid carers: Developing a proxy version of the adult social care outcomes toolkit (ASCOT). BMC Health Services Research, 19, 201.
Moher, D., Pham, B., Klassen, T. P., Schulz, K. F., Berlin, J. A., Jadad, A. R., & Liberati, A. (2000). What contributions do languages other than English make on the results of meta-analyses? Journal of Clinical Epidemiology, 53(9), 964–972.
Kinghorn, P., & Afentou, N. (2020). Proxy responses to ICECAP-A: exploring variation across multiple proxy assessments of capability well-being for the same individuals. PLoS ONE, 15(7), e0236584.
Roydhouse, J. K., Gutman, R., Keating, N. L., Mor, V., & Wilson, I. B. (2018). Differences between proxy and patient assessments of cancer care experiences and quality ratings. Health Services Research, 53(2), 919–943.
Roydhouse, J. K., Gutman, R., Keating, N. L., Mor, V., & Wilson, I. B. (2018). Proxy and patient reports of health-related quality of life in a national cancer survey. Health and Quality of Life Outcomes, 16(1), 6.
Roydhouse, J. K., Gutman, R., Wilson, I. B., Kehl, K. L., & Keating, N. L. (2020). Patient and proxy reports regarding the experience of treatment decision-making in cancer care. Psycho-Oncology, 29(11), 1943–1950.
Smith, G. E., & Bondi, M. W. (2013). Mild cognitive impairment and dementia: definitions, diagnosis, and treatment. Oxford University Press.
Alzheimers Association. (2020). 2020 Alzheimer’s disease facts and figures. Alzheimers Dement.
Aarsland, D., Zaccai, J., & Brayne, C. (2005). A systematic review of prevalence studies of dementia in Parkinson’s disease. Movement Disorders, 20(10), 1255–1263.